The difference between RPR and FTA-ABS is what each one measures and when it's used. RPR is a nontreponemal screening test that looks for the body's general reaction to syphilis-related damage; FTA-ABS is a treponemal confirmatory test that detects antibodies specific to the syphilis bacterium. Syphilis diagnosis uses both, in sequence.
| Item | Days after exposure |
|---|---|
| Chlamydia / gonorrhea (NAAT) | ~14 |
| HIV — NAT | 10–33 |
| HIV — antigen/antibody | 18–45 |
| HIV — rapid antibody | 23–90 |
If you've had a syphilis test come back "reactive," or you saw both acronyms on a lab order, this is what's going on. Diagnosing syphilis takes two steps, designed to catch true infections while filtering out false alarms. RPR and FTA-ABS sit on opposite ends of that logic. For the broader picture of how the blood work is collected and read, see our full guide to the syphilis test.
What each test is
RPR (Rapid Plasma Reagin)
RPR is a nontreponemal test. It doesn't look for the syphilis bacterium (Treponema pallidum) directly. Instead, it detects antibodies the body makes against cardiolipin, a substance released when cells are damaged during a syphilis infection. Because it measures the body's reaction rather than the germ itself, RPR is cheap, fast, and easy to automate, so it's used to screen large numbers of samples.
RPR also gives a titer, a number like 1:8 or 1:32 that reflects how much antibody is present. That titer makes RPR useful beyond a yes/no. It rises with active infection and falls after successful treatment, so clinicians track it over time to confirm a cure or spot a reinfection. A treponemal test like FTA-ABS can't do that.
FTA-ABS (Fluorescent Treponemal Antibody Absorption)
FTA-ABS is a treponemal test. It detects antibodies aimed specifically at Treponema pallidum itself, using fluorescent tagging to confirm whether your immune system has ever encountered the syphilis bacterium. It's more specific than RPR, so it serves as a confirmatory step rather than a first screen.
FTA-ABS, like treponemal tests in general, usually stays positive for life, even after you've been cured. So it answers "have you ever had syphilis?" but not "do you have it right now?" The two tests divide the labor along that line.
The key differences
What they detect
RPR detects a nonspecific marker of tissue damage; FTA-ABS detects antibodies against the actual organism. Because RPR is nonspecific, it can occasionally turn reactive from things unrelated to syphilis: pregnancy, certain autoimmune conditions, other infections, or recent vaccination. These "biological false positives" are the main reason a single reactive RPR is never treated as a diagnosis on its own.
How the result is used
A two-step process protects you against acting on a false positive. Syphilis, like HIV, uses an initial screening test followed by a different confirmatory test, and the result isn't final until the confirmatory step agrees CDC, HIV Testing. RPR screens; FTA-ABS (or another treponemal test) confirms. Many labs run the reverse sequence, a treponemal test first, then RPR to assess activity, under current CDC laboratory recommendations CDC, 2024.
Whether they track treatment
RPR's titer falls after effective treatment, so it's the test repeated weeks and months later to prove the antibiotics worked. FTA-ABS generally stays positive permanently, so repeating it after treatment tells you nothing about whether you're cured. To monitor your response, a clinician orders RPR.
RPR vs FTA-ABS side by side
| Feature | RPR | FTA-ABS |
|---|---|---|
| Type | Nontreponemal (screening) | Treponemal (confirmatory) |
| What it detects | Antibodies to cell-damage marker (cardiolipin) | Antibodies specific to T. pallidum |
| Gives a titer? | Yes — numeric, rises and falls | No — essentially positive/negative |
| False positives | More common (pregnancy, autoimmune, other infections) | Rare |
| After successful treatment | Titer falls — used to confirm cure | Usually stays positive for life |
| Primary role | Screen large numbers, monitor treatment | Confirm a reactive screen |
Which one applies to you
You usually don't choose; the lab and your clinician do, based on the testing algorithm they run. What matters for you is interpreting your results:
- [object Object]
- [object Object]
- [object Object]
- [object Object]
As with any blood test, timing matters. There's a window period between exposure and when antibodies are detectable, so a too-early test can read falsely negative because the infection isn't detectable yet. If your exposure was recent, read up on when to test after exposure before assuming a negative is the final word.
The practical next step
Syphilis is checked with a quick blood draw, the same draw used for HIV and hepatitis, so it's minutes in the chair, with results usually back in a day or a few USPSTF. You don't need to fast or prepare. If you're getting screened for a panel, the chlamydia and gonorrhea portion is a urine cup or self-collected swab run as a NAAT, the most sensitive method available CDC; learn more about chlamydia if that's part of your concern.
Cost is rarely the barrier people fear. Testing is free or income-based at health departments, Planned Parenthood, and Title X family-planning clinics, and the country has thousands of federally funded community health centers within reach of most people HRSA. You can get tested at any of these, and at-home kits exist too. Just mind the window period so you test at the right time.
When to talk to a clinician
Talk to a clinician if you have a reactive or positive result of any kind, if you have symptoms (a painless sore, a body rash including the palms and soles, swollen glands), if you're pregnant, or if a partner has tested positive. Syphilis is treatable, but it's staged, and the stage drives the treatment plan and the follow-up titer schedule. Don't try to interpret a lab report alone; the combination of tests, your titer, and your history is what gives the answer.